Xpert® Xpress Flu
A multi-target approach for the detection of influenza to mitigate potential impact of genetic shift and drift on strain detection
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
product image
10 Tests
XPRSFLU-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Collection devices
product image
Copan 3C057N (Nasopharyngeal Swab) (Pack of 50)
3C057N
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
product image
Copan 3C064N (Nasal Swab) (Pack of 50)
3C064N
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support

The Need

  • Respiratory viruses, especially influenza, mutate rapidly and novel strains can emerge with little notice.
  • Sensitivities of Rapid EIA Flu tests range from 50-70%1
  • This genetic evolution can potentially impact the performance of molecular diagnostic tests if mutations occur within the test’s targeted regions.2
(1) CDC. Information for Clinicians on Rapid Diagnostic Testing for Influenza. https://www.cdc.gov/flu/professionals/diagnosis/rapidclin.htm#:~:text=Sensitivities%20of%20rapid%20 influenza%20diagnostic%20tests%20are%20low,culture%20or%20reverse%20transcription%20polymerase%20chain%20reaction%20%28RT-PCR%29. Accessed June 2023.
(2) Jørgensen RL, Lerche CJ, Pedersen MS, Kirkby NS, Botnen AB, Trebbien R, Nilsson-Møller S, Pinholt M,Nielsen ACY, Westh H, Lisby JG, Schneider UV. Emergence of circulating influenza A H3N2 viruses with genetic drift in the matrix gene: be alert of false-negative test results. APMIS. 2022; 130: 612–617.

The Solution

Cepheid’s Xpert Xpress Flu test utilizes a multi-target approach for the detection of influenza, providing target redundancy to mitigate potential impact of genetic shift and drift on strain detection.
Accurate and reliable detection of Flu A and Flu B in as soon as 20 minutes*
  • Accurate and reliable detection of Flu A and Flu B in as soon as 20 minutes*
  • Enables healthcare providers to quickly deliver targeted therapies
  • Streamlines laboratory operations
  • Improves patient satisfaction
* With early assay termination for positive results, full run time is approximately 30

The Impact

Single-test confidence will accelerate your laboratory’s workflow with on-demand, random-access flexibility. Combine performance with the capability to run other Xpert® tests on Cepheid’s GeneXpert® system to achieve proven productivity increases in overall laboratory service. System to achieve proven productivity increases in overall laboratory service.3,4

Be Proactive
  • Achieve rapid results and improve patient management
  • Early assay termination option: deliver positive results in as soon as 20 minutes* and negative results in 30 minutes
  • Quickly deliver targeted therapies and increase peace of mind for patients
* With early assay termination for positive results, full run time is approximately 30 mins.
(3) Morgan MG. The Perfect Storm. Cepheid Impact. 2023 Jun;2:4-7.
(4) Parada JP. Increase Revenue and Improve Patient Safety. Cepheid Impact. 2023 Jun;2:8-11.
(5) Aretzweiler, et al. Generating timely molecular diagnostic test results: workflow comparison of the cobas® 6800/8800 to Panther. Expert Rev Mol Diagn. 2019 Oct;19(10):951-957